土耳其属植物物种:植物学方面,二次代谢物和生物转化
Güner Ekiz Dinçman1, Zeki Aytaç2, İhsan Çalış3
1Near East University, Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Lefkoşa (Nicosia), TRNC, Mersin-10, Turkey.
Planta medica
|November 13, 2024
概括
这篇评论探讨了土耳其花的物种,突出了它们丰富的植物化学成分,特别是具有多样化生物活性的环氧化合物. 环氨基醇作为端粒酶激活剂具有前景,具有衍生品开发的潜力.
科学领域:
- 药理学是指药理学,即药理学是指药理学.
- 民族植物学 民族植物学
- 自然产品化学 自然产品化学
背景情况:
- 阿斯特拉加勒斯L.是一种多样化的属,全球约有3500个物种,在土耳其有485个种类,以高度的特有性而闻名.
- 传统医药利用阿斯特拉加勒斯根治疗各种疾病,包括利尿和增强力目的,以及治疗炎和糖尿病.
- 这种属性是循环阿类化合物的重要来源,具有广泛的生物活性,包括伤口愈合和抗瘤作用.
研究的目的:
- 审查土耳其阿斯特拉加勒斯物种的植物学,植物化学和生物活性研究.
- 专注于循环阿醇及其衍生物,特别是循环阿烯醇作为端粒酶激活剂.
- 为了总结使用内菌的Astragaluscycloartanes生物转化研究.
主要方法:
- 36篇关于土耳其阿斯特拉加勒斯物种的文献评论.
- 植物化学分析识别了新的化合物,主要是三二烯沙素.
- 涉及内菌的生物转化研究的摘要.
主要成果:
- 鉴定了来自29种土耳其属植物的111种新化合物,其中104种是三烯.
- 突出了循环阿类化合物的流行及其多样化的生物活性.
- 详细的生物转化由内性真菌的阿斯特拉加勒斯cycloartanes.
结论:
- 土耳其阿斯特拉加勒斯物种是生物活性环亚化合物的丰富来源.
- 环氨基醇及其衍生物具有治疗应用的巨大潜力,特别是作为端粒酶激活剂.
- 内生菌提供了Astragalus cycloartanes生物转化途径,扩大了它们的化学多样性和生物活性.
相关概念视频
Drug Biotransformation: Overview
2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K
Factors Affecting Drug Biotransformation: Biological
116
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
116
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
191
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
191
Phase II Reactions: Glucuronidation
301
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
301
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
178
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
178
Drug Metabolism: Phase II Reactions
3.7K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.7K


